Search

You searched for "child"

2445 results found

3D printing and ophthalmology

3 August 2023 | | EYE - General
3D printers have been available in the home market for many years, with the range of models increasing over time and the costs reducing. Historically, 3D printers have built a reputation of being complex and uncommon, most needing significant assembly...

Navigating an Ophthalmology Lab-Based Research Elective: Reflections and Insights from Johns Hopkins Wilmer Eye Institute

10 November 2025 | | EYE - Cornea
Medical school electives offer valuable opportunities to gain exposure to different healthcare systems and bridge specific gaps in training. While clinical electives are often the primary choice for medical students, research-focused electives also present unique benefits, particularly for those interested...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Blind Inverclyde woman finds her voice

20 June 2025 | charity, patient stories, scotland, news
Claire Forde (29) from Greenock is no stranger to a microphone. Her journey into public speaking took a major step forward this year when she joined a newly launched Speakers Club, created to improve the confidence and communication skills of...

New guidance demands robust training and governance as robotic surgery rolls out across NHS hospitals

9 December 2025 | technology, clinical practice, NHS, surgery, education
The Royal College of Surgeons of England (RCS England) has issued new guidance urging NHS Trusts to strengthen training and tighten governance for surgeons performing robotic procedures, amid growing use of the technology in operating theatres. The recommendations come as...

Traffic Lights

4 December 2024 | | EYE - Vitreo-Retinal, EYE - Pathology
For this issue’s instalment of The Culture Section, I was privileged to speak to Moorfield’s first prize competition winner Charlotte Zheng. Earlier this year in January, Charlotte wrote a patient reflection poem for the prize competition titled ‘Patient as Teacher...

Updated Supervision eligibility, opportunities and support for Scheme of Registration from 1 July 2026

26 June 2026 | optometry, training
From 1 July 2026, supervision arrangements on the Scheme for Registration will align with the model already used in Clinical Learning in Practice (CLiP). This marks the final stage of the transition to supervision arrangements designed to meet the GOC’s...

Visually impaired secret shoppers put fringe accessibility to the test

28 August 2026 | charity, patient stories
Visually impaired secret shoppers are going undercover at Edinburgh Festival Fringe venues to put accessibility to the test, assessing whether training and awareness work are translating into a better experience for disabled audiences. The volunteers, who have helped deliver accessibility...

Alcon UK and Ireland Announces the Launch of UNITY™ M:

19 October 2026
- Sponsored Content - The next generation of ophthalmic microscopy has arrived in the UK and Ireland. UNITY™ M has been designed to balance the demands for enhanced visualisation with exceptional control, precision,* and adaptivity.1-4 UNITY™ M delivers: Modular by...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

Could Twitter boost the impact of ophthalmic journal articles?

1 October 2021 | | EYE - General
*Equally contributing co-first authors. The authors investigate the link between ‘tweets’ and citations for 155 articles from five key ophthalmology journals. Social media’s impact on our lives has been significant, allowing easy discussion of topics worldwide. An increasing number of...